FORM OF LETTER TO STOCKHOLDERS REGARDING AMENDMENT OF RIGHTS AGREEMENT [La Jolla Pharmaceutical Letterhead]
EXHIBIT 99.3
[La Jolla Pharmaceutical Letterhead]
December 14, 2005
Dear Stockholder:
Effective as of December 14, 2005, La Jolla Pharmaceutical Company and American Stock
Transfer & Trust Company entered into Amendment No. 2 to Rights Agreement, dated December 3,
1998, as amended, by and between La Jolla Pharmaceutical Company and American Stock Transfer &
Trust Company. Amendment No. 2 amended the definition of “Acquiring Person” to permit Essex
Woodlands Health Ventures Fund VI, L.P. to invest up to a level just under 29% beneficial
ownership of the Company and to permit Xxxxxxx Healthcare V, LP to invest up to a level just
under 19% beneficial ownership of the Company without triggering the issuance of rights under to
the Rights Agreement.
The attached “Summary of Rights” describes the Rights Agreement, as amended, in more detail
and supersedes any prior Summary of Rights distributed to you. We urge you to read the attached
summary. Thank you for your continued support of La Jolla Pharmaceutical Company.
| Sincerely, |
||||
| /s/ Xxxxxx X. Xxxxx | ||||
| Xxxxxx X. Xxxxx Chief Executive Officer |
||||
